Will seek regulatory approval
Good news for parents worried about sending their kids to school amid the pandemic.
Pfizer announcing today its COVID-19 vaccine works for children ages 5 to 11.
The next step is getting approval from regulators in the U.S.. Britain and Europe to begin with.
Pfizer studied the vaccine in more than 2,000 kindergartners and elementary school-aged kids.
It gave them about a third of the typical dose and found they developed antibody levels just as strong as teens and young adults.

Kristen French Centre Battling Online Luring
Niagara's Crime Severity Rate Drops
Man Dies in Niagara Falls Motorcycle Crash
2nd Niagara Falls Murder Suspect Arrested
Suspect Wanted After Cables Cut
Candidates Splurge on Election Signs
Homeless, City Finances Top Candidate's Concerns
Police Investigation Resolved